146 related articles for article (PubMed ID: 12969999)
21. Flunisolide HFA.
Waugh J; Goa KL
Am J Respir Med; 2002; 1(5):369-72; discussion 373. PubMed ID: 14720039
[TBL] [Abstract][Full Text] [Related]
22. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.
Karpel JP; Nayak A; Lumry W; Craig TJ; Kerwin E; Fish JE; Lutsky B
Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813
[TBL] [Abstract][Full Text] [Related]
23. Flunisolide for the treatment of asthma.
Melani AS
Expert Rev Clin Pharmacol; 2014 May; 7(3):251-8. PubMed ID: 24716719
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma.
Corren J; Tashkin DP
Clin Ther; 2003 Mar; 25(3):776-98. PubMed ID: 12852702
[TBL] [Abstract][Full Text] [Related]
25. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids.
Wolfe J; Rooklin A; Grady J; Munk ZM; Stevens A; Prillaman B; Duke S; Harding S
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1153-61. PubMed ID: 10856150
[TBL] [Abstract][Full Text] [Related]
26. Corticosteroids administered by nebulization to children with bronchial asthma.
Terzano C; Barkai L; Cremonesi G
Adv Ther; 2001; 18(6):253-60. PubMed ID: 11841195
[TBL] [Abstract][Full Text] [Related]
27. e-NO peak versus e-NO plateau values in evaluating e-NO production in steroid-naive and in steroid-treated asthmatic children and in detecting response to inhaled steroid treatment.
Silvestri M; Spallarossa D; Battistini E; Fregonese B; Rossi GA
Pediatr Pulmonol; 2001 Jan; 31(1):37-43. PubMed ID: 11180673
[TBL] [Abstract][Full Text] [Related]
28. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.
Corren J; Korenblat PE; Miller CJ; O'Brien CD; Mezzanotte WS
Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902
[TBL] [Abstract][Full Text] [Related]
29. Treatment with inhaled flunisolide.
Edmonds ML; Rowe BH
Chest; 2004 May; 125(5):1961-2; author reply 1962-3. PubMed ID: 15136418
[No Abstract] [Full Text] [Related]
30. Six-week trial of nebulized flunisolide nasal spray: efficacy in young children with moderately severe asthma.
Allen ED; Whitaker ER; Ryu G
Pediatr Pulmonol; 1997 Dec; 24(6):397-405. PubMed ID: 9448231
[TBL] [Abstract][Full Text] [Related]
31. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma.
Schuh S; Dick PT; Stephens D; Hartley M; Khaikin S; Rodrigues L; Coates AL
Pediatrics; 2006 Aug; 118(2):644-50. PubMed ID: 16882819
[TBL] [Abstract][Full Text] [Related]
32. Does ketotifen have a steroid-sparing effect in childhood asthma?
Canny GJ; Reisman J; Levison H
Eur Respir J; 1997 Jan; 10(1):65-70. PubMed ID: 9032494
[TBL] [Abstract][Full Text] [Related]
33. Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network.
Kamada AK; Szefler SJ; Martin RJ; Boushey HA; Chinchilli VM; Drazen JM; Fish JE; Israel E; Lazarus SC; Lemanske RF
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1739-48. PubMed ID: 8665030
[No Abstract] [Full Text] [Related]
34. Comparison of the efficacy of inhaled fluticasone propionate, 880 microg/day, with flunisolide, 1500 microg/day, in moderate-to-severe persistent asthma.
Sheikh S; Goldsmith LJ; Howell L; Eid N
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):300-4. PubMed ID: 10541421
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of budesonide administered via dry-powder inhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler for adults with persistent asthma in managed care settings.
Weiss KB; Liljas B; Schoenwetter W; Schatz M; Luce BR
Clin Ther; 2004 Jan; 26(1):102-14. PubMed ID: 14996523
[TBL] [Abstract][Full Text] [Related]
36. A comparison of double-strength beclomethasone dipropionate (84 microg) MDI with beclomethasone dipropionate (42 microg) MDI in the treatment of asthma.
Nathan RA; Nolop KB; Cuss FM; Lorber RR
Chest; 1997 Jul; 112(1):34-9. PubMed ID: 9228354
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of budesonide/formoterol pMDI vs budesonide pMDI in asthmatic children (6-<12 years).
Pearlman DS; Eckerwall G; McLaren J; Lamarca R; Puu M; Gilbert I; Jorup C; Sandin K; Lanz MJ
Ann Allergy Asthma Immunol; 2017 Apr; 118(4):489-499.e1. PubMed ID: 28256307
[TBL] [Abstract][Full Text] [Related]
38. Inhaled lidocaine for the treatment of asthma: lack of efficacy in two double-blind, randomized, placebo-controlled clinical studies.
Abuan T; Yeager M; Montgomery AB
J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):381-8. PubMed ID: 20958143
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
[TBL] [Abstract][Full Text] [Related]
40. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma.
Schuh S; Reisman J; Alshehri M; Dupuis A; Corey M; Arseneault R; Alothman G; Tennis O; Canny G
N Engl J Med; 2000 Sep; 343(10):689-94. PubMed ID: 10974132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
